These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7747291)

  • 1. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
    Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
    Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
    Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
    Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
    Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
    PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
    Roy SK; Islam A; Ali R; Islam KE; Khan RA; Ara SH; Saifuddin NM; Fuchs GJ
    Trans R Soc Trop Med Hyg; 1998; 92(4):460-2. PubMed ID: 9850410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistant Vibrio cholerae O1.
    Burans JP; Podgore J; Mansour MM; Farah AH; Abbas S; Abu-Elyazeed R; Woody JN
    Trans R Soc Trop Med Hyg; 1989; 83(6):836-8. PubMed ID: 2617655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection.
    Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M
    Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania.
    Urassa WK; Mhando YB; Mhalu FS; Mjonga SJ
    East Afr Med J; 2000 Jul; 77(7):350-3. PubMed ID: 12862151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.
    Gotuzzo E; Seas C; Echevarría J; Carrillo C; Mostorino R; Ruiz R
    Clin Infect Dis; 1995 Jun; 20(6):1485-90. PubMed ID: 7548496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
    Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
    Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose azithromycin for the treatment of cholera in adults.
    Saha D; Karim MM; Khan WA; Ahmed S; Salam MA; Bennish ML
    N Engl J Med; 2006 Jun; 354(23):2452-62. PubMed ID: 16760445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
    Khan WA; Saha D; Rahman A; Salam MA; Bogaerts J; Bennish ML
    Lancet; 2002 Nov; 360(9347):1722-7. PubMed ID: 12480424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial.
    Saha D; Khan WA; Karim MM; Chowdhury HR; Salam MA; Bennish ML
    Lancet; 2005 Sep 24-30; 366(9491):1085-93. PubMed ID: 16182896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp.
    Uylangco C; Santiago L; Pescante M; Menday P; Christensen O
    J Antimicrob Chemother; 1984 Feb; 13(2):171-5. PubMed ID: 6323378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial.
    Kaushik JS; Gupta P; Faridi MM; Das S
    Indian Pediatr; 2010 Apr; 47(4):309-15. PubMed ID: 19578229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose tetracycline in cholera.
    Islam MR
    Gut; 1987 Aug; 28(8):1029-32. PubMed ID: 3311904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children.
    Kabir I; Khan WA; Haider R; Mitra AK; Alam AN
    J Diarrhoeal Dis Res; 1996 Dec; 14(4):243-7. PubMed ID: 9203786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.